NU 641 Advanced Clinical Pharmacology Exam 2
Study Guide
This professional clinical resource is a premier test bank explicitly engineered for
graduate nursing students preparing for the high-stakes NU 641 Advanced Clinical
Pharmacology Examination 2. It delivers a high-yield collection of board-style practice
questions, 100% verified correct answers, and comprehensive prescriptive
rationales tailored for advanced practice providers. Reviewing these premium testing
parameters ensures absolute competence across the mechanisms of action,
pharmacokinetics, adverse effect profiles, and black box warnings of major therapeutic
classes—including advanced cardiovascular, renal, respiratory, and central nervous
system medications—to guarantee an A grade on your proctored university
assessment.
SET 1: Cardiovascular Pharmacology – Hypertension and
Heart Failure (Questions 1–40)
1. A 68-year-old patient with heart failure and reduced ejection fraction (HFrEF) is
started on sacubitril/valsartan. Which mechanism best explains why this combination
reduces cardiovascular mortality more than an ACE inhibitor alone?
A. It blocks angiotensin II receptors while simultaneously inhibiting neprilysin
B. It irreversibly inhibits ACE, producing a more sustained reduction in aldosterone
C. It selectively blocks beta-1 receptors and reduces myocardial oxygen demand
D. It inhibits the sodium-glucose cotransporter-2, promoting natriuresis
Answer: A. It blocks angiotensin II receptors while simultaneously inhibiting
neprilysin
,Rationale: Sacubitril inhibits neprilysin, raising natriuretic peptide levels, while valsartan
blocks angiotensin II AT1 receptors. This dual action outperformed enalapril in the
PARADIGM-HF trial .
2. Which medication helps rebalance myocardial oxygen supply and demand in angina
by increasing supply through coronary vasodilation?
A. Metoprolol
B. Amlodipine
C. Nitroglycerin
D. Ranolazine
Answer: C. Nitroglycerin
Rationale: Nitroglycerin is a potent vasodilator that primarily reduces preload but also
dilates coronary arteries, improving myocardial oxygen supply .
3. A patient with atrial fibrillation is on warfarin with a therapeutic INR. They are started
on amiodarone. Two weeks later, the INR is 4.8 without bleeding. Which mechanism
explains this?
A. Amiodarone inhibits CYP2C9 and CYP1A2, reducing warfarin metabolism
B. Amiodarone induces CYP3A4, increasing warfarin clearance
C. Amiodarone displaces warfarin from albumin binding sites
D. Amiodarone increases warfarin renal excretion
Answer: A. Amiodarone inhibits CYP2C9 and CYP1A2, reducing warfarin
metabolism
Rationale: Amiodarone is a potent inhibitor of CYP2C9 and CYP1A2, the primary enzymes
metabolizing warfarin. This reduces clearance and increases INR .
4. A patient with severe heart failure and hypovolemia is prescribed an ACE inhibitor.
Which adverse effect should the nurse practitioner monitor for most closely?
A. Hyperkalemia
,B. Hypotension
C. Dry cough
D. Angioedema
Answer: B. Hypotension
Rationale: ACE inhibitors reduce afterload and preload, which can cause significant
hypotension, especially in volume-depleted patients.
5. Which drug is a selective beta-1 blocker that reduces heart rate and myocardial
contractility in heart failure?
A. Carvedilol
B. Metoprolol succinate
C. Propranolol
D. Labetalol
Answer: B. Metoprolol succinate
Rationale: Metoprolol succinate is a beta-1 selective blocker with evidence for mortality
benefit in HFrEF. Carvedilol is non-selective.
6. A patient on a thiazide diuretic develops low potassium. Which medication can be
added to help reverse low potassium levels?
A. Spironolactone
B. Furosemide
C. Hydrochlorothiazide
D. Mannitol
Answer: A. Spironolactone
Rationale: Spironolactone is a potassium-sparing diuretic that helps retain potassium,
counteracting thiazide-induced hypokalemia .
, 7. Which antihypertensive class is preferred in a patient with diabetes and proteinuria?
A. Beta blockers
B. ACE inhibitors
C. Thiazide diuretics
D. Calcium channel blockers
Answer: B. ACE inhibitors
Rationale: ACE inhibitors are renoprotective and reduce proteinuria in diabetic patients,
making them first-line for hypertension in this population .
8. A patient with heart failure is prescribed furosemide. Which instruction should the
nurse practitioner include?
A. Take at bedtime
B. Increase potassium-rich foods
C. Avoid sunlight
D. Take with antacids
Answer: B. Increase potassium-rich foods
Rationale: Furosemide is a loop diuretic that causes potassium loss. Patients should
increase potassium intake .
9. Which finding indicates digoxin toxicity?
A. Heart rate 58 bpm
B. Nausea and visual changes
C. Blood pressure 110/70 mm Hg
D. Mild fatigue
Answer: B. Nausea and visual changes
Rationale: Nausea and visual disturbances (yellow halos) are classic signs of digoxin
toxicity. Digoxin has a narrow therapeutic index .
Study Guide
This professional clinical resource is a premier test bank explicitly engineered for
graduate nursing students preparing for the high-stakes NU 641 Advanced Clinical
Pharmacology Examination 2. It delivers a high-yield collection of board-style practice
questions, 100% verified correct answers, and comprehensive prescriptive
rationales tailored for advanced practice providers. Reviewing these premium testing
parameters ensures absolute competence across the mechanisms of action,
pharmacokinetics, adverse effect profiles, and black box warnings of major therapeutic
classes—including advanced cardiovascular, renal, respiratory, and central nervous
system medications—to guarantee an A grade on your proctored university
assessment.
SET 1: Cardiovascular Pharmacology – Hypertension and
Heart Failure (Questions 1–40)
1. A 68-year-old patient with heart failure and reduced ejection fraction (HFrEF) is
started on sacubitril/valsartan. Which mechanism best explains why this combination
reduces cardiovascular mortality more than an ACE inhibitor alone?
A. It blocks angiotensin II receptors while simultaneously inhibiting neprilysin
B. It irreversibly inhibits ACE, producing a more sustained reduction in aldosterone
C. It selectively blocks beta-1 receptors and reduces myocardial oxygen demand
D. It inhibits the sodium-glucose cotransporter-2, promoting natriuresis
Answer: A. It blocks angiotensin II receptors while simultaneously inhibiting
neprilysin
,Rationale: Sacubitril inhibits neprilysin, raising natriuretic peptide levels, while valsartan
blocks angiotensin II AT1 receptors. This dual action outperformed enalapril in the
PARADIGM-HF trial .
2. Which medication helps rebalance myocardial oxygen supply and demand in angina
by increasing supply through coronary vasodilation?
A. Metoprolol
B. Amlodipine
C. Nitroglycerin
D. Ranolazine
Answer: C. Nitroglycerin
Rationale: Nitroglycerin is a potent vasodilator that primarily reduces preload but also
dilates coronary arteries, improving myocardial oxygen supply .
3. A patient with atrial fibrillation is on warfarin with a therapeutic INR. They are started
on amiodarone. Two weeks later, the INR is 4.8 without bleeding. Which mechanism
explains this?
A. Amiodarone inhibits CYP2C9 and CYP1A2, reducing warfarin metabolism
B. Amiodarone induces CYP3A4, increasing warfarin clearance
C. Amiodarone displaces warfarin from albumin binding sites
D. Amiodarone increases warfarin renal excretion
Answer: A. Amiodarone inhibits CYP2C9 and CYP1A2, reducing warfarin
metabolism
Rationale: Amiodarone is a potent inhibitor of CYP2C9 and CYP1A2, the primary enzymes
metabolizing warfarin. This reduces clearance and increases INR .
4. A patient with severe heart failure and hypovolemia is prescribed an ACE inhibitor.
Which adverse effect should the nurse practitioner monitor for most closely?
A. Hyperkalemia
,B. Hypotension
C. Dry cough
D. Angioedema
Answer: B. Hypotension
Rationale: ACE inhibitors reduce afterload and preload, which can cause significant
hypotension, especially in volume-depleted patients.
5. Which drug is a selective beta-1 blocker that reduces heart rate and myocardial
contractility in heart failure?
A. Carvedilol
B. Metoprolol succinate
C. Propranolol
D. Labetalol
Answer: B. Metoprolol succinate
Rationale: Metoprolol succinate is a beta-1 selective blocker with evidence for mortality
benefit in HFrEF. Carvedilol is non-selective.
6. A patient on a thiazide diuretic develops low potassium. Which medication can be
added to help reverse low potassium levels?
A. Spironolactone
B. Furosemide
C. Hydrochlorothiazide
D. Mannitol
Answer: A. Spironolactone
Rationale: Spironolactone is a potassium-sparing diuretic that helps retain potassium,
counteracting thiazide-induced hypokalemia .
, 7. Which antihypertensive class is preferred in a patient with diabetes and proteinuria?
A. Beta blockers
B. ACE inhibitors
C. Thiazide diuretics
D. Calcium channel blockers
Answer: B. ACE inhibitors
Rationale: ACE inhibitors are renoprotective and reduce proteinuria in diabetic patients,
making them first-line for hypertension in this population .
8. A patient with heart failure is prescribed furosemide. Which instruction should the
nurse practitioner include?
A. Take at bedtime
B. Increase potassium-rich foods
C. Avoid sunlight
D. Take with antacids
Answer: B. Increase potassium-rich foods
Rationale: Furosemide is a loop diuretic that causes potassium loss. Patients should
increase potassium intake .
9. Which finding indicates digoxin toxicity?
A. Heart rate 58 bpm
B. Nausea and visual changes
C. Blood pressure 110/70 mm Hg
D. Mild fatigue
Answer: B. Nausea and visual changes
Rationale: Nausea and visual disturbances (yellow halos) are classic signs of digoxin
toxicity. Digoxin has a narrow therapeutic index .
